Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals

BACKGROUND: The global pandemic of coronavirus disease 2019 (COVID-19) is caused by infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against SARS-CoV-2 in the USA, including two based on messenger RNA (mRNA) technology that has demonstrated high vaccine efficacy. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraley, Elizabeth, LeMaster, Cas, Geanes, Eric, Banerjee, Dithi, Khanal, Santosh, Grundberg, Elin, Selvarangan, Rangaraj, Bradley, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310732/
https://www.ncbi.nlm.nih.gov/pubmed/34304742
http://dx.doi.org/10.1186/s12916-021-02055-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310732/
https://www.ncbi.nlm.nih.gov/pubmed/34304742
http://dx.doi.org/10.1186/s12916-021-02055-9

Ejemplares similares